References
May 1, 1990·Pharmacology, Biochemistry, and Behavior·J BruhwylerM Mercier
Sep 1, 1988·Archives of General Psychiatry·J KaneH Meltzer
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·J UrquhartK L Willis
Sep 1, 1982·Biology of Reproduction·J F NelsonC E Finch
Dec 15, 1993·Biological Psychiatry·S B SchwarzkopfN N Boutros
Oct 8, 1997·Mammalian Genome : Official Journal of the International Mammalian Genome Society·D C RogersJ E Martin
Dec 31, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·N R SwerdlowM A Geyer
Jun 5, 1998·Schizophrenia Bulletin·N R Swerdlow, M A Geyer
Jan 8, 1999·Brain Research·K M Bishop, D Wahlsten
Feb 13, 1999·International Clinical Psychopharmacology·D TaylorR Murray
Aug 27, 1999·Progress in Neurobiology·M Koch
Mar 17, 2000·Brain Research. Brain Research Reviews·N C Andreasen
Dec 28, 2000·Behavioural Brain Research·J LehmannJ Feldon
Sep 6, 2001·Acta neurochirurgica·K Wester, J Kråkenes
Sep 11, 2001·Psychopharmacology·D L BraffN R Swerdlow
Jul 20, 2002·International Clinical Psychopharmacology·P BrambillaC Barbui
Dec 3, 2002·Psychopharmacology·Johanna K SimoskyRobert Freedman
Jun 19, 2004·Psychopharmacology·Bita Moghaddam
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·William M Pardridge
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Dec 16, 2005·Molecular Psychiatry·T R Insel, E M Scolnick
Dec 20, 2005·Psychopharmacology·Gary E DuncanBeverly H Koller
Mar 17, 2006·Schizophrenia Bulletin·Shôn W LewisPeter B Jones
May 16, 2006·CNS Drugs·Jiri HoracekCyril Höschl
Jun 27, 2006·Biological Psychiatry·Craig M Powell, Tsuyoshi Miyakawa
Sep 26, 2006·Biological Psychiatry·Franz X VollenweiderJorame Feldon
Apr 20, 2007·Epilepsia·Wolfgang Löscher
Aug 2, 2007·Molecular Psychiatry·C E McOmishA J Hannan
Nov 30, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·William T Carpenter, James I Koenig
Jan 8, 2008·Schizophrenia Research·Daniel J AbramsKaren E Stevens
Apr 1, 2008·Lancet·René S KahnUNKNOWN EUFEST study group
Apr 23, 2008·Current Protocols in Neuroscience·M A Geyer, N R Swerdlow
Jun 13, 2008·Pharmacology, Biochemistry, and Behavior·Alexa MeadShitij Kapur
Jul 3, 2008·The International Journal of Neuropsychopharmacology·Laura GrayAnthony J Hannan
Nov 18, 2008·Schizophrenia Bulletin·Peter F BuckleyDavid J Castle
Apr 29, 2009·Behavioural Brain Research·Susan B PowellMark A Geyer
Jun 6, 2009·The International Journal of Neuropsychopharmacology·Andrea GogosSusan Rossell
Jun 9, 2009·Journal of Neuroscience Methods·Nelson G PublicoverKenneth W Hunter
Feb 17, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tomás PálenícekJirí Horácek
Sep 21, 2010·Clinical Neuropharmacology·Susanne EnglischMathias Zink
Dec 17, 2010·The Open Medicinal Chemistry Journal·Akito Yasuhara, Shigeyuki Chaki
Apr 5, 2011·Behavioural Brain Research·Anand GururajanDaniel Thomas Malone
Apr 6, 2011·Behavioral Neuroscience·David FeifelGilia Melendez
Jul 30, 2011·Psychopharmacology·Andrea GogosMaarten van den Buuse
Sep 2, 2011·British Journal of Pharmacology·Shunske TanahashiMotohiro Okada
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Bita Moghaddam, Daniel Javitt
Nov 30, 2011·Current Drug Safety·Michele Raja
Apr 13, 2012·Journal of Psychopharmacology·Anand GururajanDaniel T Malone
Jun 5, 2012·Brain Research·Sarah Mc FieVivienne A Russell
Jun 27, 2014·Expert Opinion on Therapeutic Targets·Kenji Hashimoto